05958909 is referenced by 48 patents and cites 27 patents.
Derivatives of glucagon-like peptide I (GLP-1) and especially GLP-1(7-36) have been found to have insulinotropic activity. The invention pertains to the use of GLP-1(7-36) for the treatment of type II diabetes mellitus.
Citations: 48 (view full list)
References: 27 (view full list)